4//SEC Filing
PASSERI DANIEL R 4
Accession 0001209191-19-035525
CIK 0001645460other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:12 PM ET
Size
5.1 KB
Accession
0001209191-19-035525
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2019-06-06$6.90/sh+3,000$20,700→ 50,600 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.88 to $6.92, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001190121
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:12 PM ET
- Size
- 5.1 KB